B. BRAUN SE
History
| Year | Detail |
|---|---|
| 1839 | It all began in 1839, when Julius Wilhelm Braun bought the Rose Pharmacy in Melsungen. |
| 1930 | Sterofundin was one of the first infusion solutions to be produced industrially. |
| 1935 | The non-absorbable synthetic suture material Synthofil A was launched successfully. |
| 1950 | B. Braun invested in the latest technology and started as a supplier for extracorporeal blood treatment. |
| 1950 | The development of single-use infusion equipment made of plastic. |
| 1960 | The company began to manufacture its own dialysis machines in cooperation with FRABA. |
| 1962 | B. Braun brought Lipofundin on the market, the first infusible lipid emulsion developed in Germany. |
| 1966 | Establishment of the B. Braun Foundation for promoting basic and advanced training of doctors and nursing staff. |
| 1967 | Launched first pneumatic motor. |
| 1971 | Launched The Infusomat, the first volumetric infusion pump. |
| 1989 | In cooperation with the University of Kassel, the company sets up the Otto Braun Fund to grant doctoral scholarships. |
| 1991 | B. Braun has opended its first dialysis center in Budapest, Hungary. |
| 2008 | B. Braun Avitum has had global success as a full-service supplier for extracorporeal blood treatment. |
| 2012 | Introduced Introcan Safety 3, featuring an integrated, self-sealing valve that prevents blood leakage and protects against infection. |
BCC Research Beacon